Nektar Therapeutics
NKTR
#4803
Rank
NZ$3.55 B
Marketcap
NZ$105.21
Share price
2.97%
Change (1 day)
588.01%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$17.49

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$17.55. In 2024 the company made an earnings per share (EPS) of NZ-$15.24 an increase over its 2023 EPS that were of NZ-$37.68.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$17.4914.73%
2024NZ-$15.24-59.54%
2023NZ-$37.68-25.89%
2022NZ-$50.84-31.12%
2021NZ-$73.8114.86%
2020NZ-$64.26-1.19%
2019NZ-$65.04-163.96%
2018NZ$101.69-725.4%
2017NZ-$16.26-42.73%
2016NZ-$28.3983.33%
2015NZ-$15.4939.53%
2014NZ-$11.10-69.29%
2013NZ-$36.13-6.67%
2012NZ-$38.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.03-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.25-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.91-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.66-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.12-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.96-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.60-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland